Search

everythinglearnresearchcommunity

for

Search:↓

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Plant-derived nanoparticles from Polygoni Multiflori Radix promote hair growth better than Minoxidil by affecting androgen pathways.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.